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a b s t r a c t
Serotonin (5-HT) is involved in the ﬁne adjustments at several brain centers including the core of the
mammal circadian timing system (CTS) and the hypothalamic suprachiasmatic nucleus (SCN). The SCN
receives massive serotonergic projections from the midbrain raphe nuclei, whose inputs are described
in rats as ramifying at its ventral portion overlapping the retinohypothalamic and geniculohypothala-eywords:
uprachiasmatic nucleus
erotonin receptor
allithrix jacchus
rimate
mic ﬁbers. In the SCN, the 5-HT actions are reported as being primarily mediated by the 5-HT1 type
receptor with noted emphasis for 5-HT1B subtype, supposedly modulating the retinal input in a presy-
naptic way. In this study in a New World primate species, the common marmoset (Callithrix jacchus), we
showed the 5-HT1B receptor distribution at the dorsal SCN concurrent with a distinctive location of 5-HT-
immunoreactive ﬁbers. This ﬁnding addresses to a new discussion on the regulation and synchronization
in recircadian timing system
erotonin
of the circadian rhythms
he circadian timing system (CTS) is a neural network responsible
or the generation and modulation of the circadian rhythms. The
TS of mammals comprises an encephalic circuitry, in the center
f which, the hypothalamic suprachiasmatic nucleus (SCN) is con-
eived as the main circadian pacemaker. Along the last decades,
he SCN has been investigated in respect to its major hodological,
eurochemical, and molecular features [34,37].
The rhythms generated by the SCN are synchronized by
nvironmental cues, of which the light/dark cycle is the major syn-
hronizing agent. Three main pathways reach the SCN inﬂuencing
ts activity: (1) the retinohypothalamic tract (RHT), from the retinal
lutamatergic ganglion cells [7,17,20,26]; (2) the geniculohypotha-
amic tract (GHT) [18], formed by neuropeptide Y-positive ﬁbers
14] from the thalamic intergeniculate leaﬂet [15]; and (3) the
erotonergic midbrain projections from the median raphe nucleus
16,22,25]. In rats, all of these pathways are described as ram-
fying in an overlapping way at the ventral portion of the SCN
16,26,25,35], even though that in a previous study of a New World
rimate the common marmoset (Callithrix jacchus), serotonergic
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terminal plexus was described as reaching the most dorsal portion
of the SCN in a complementary manner to the ventral RHT and GHT
projections [5,31].
The serotonergic pathway is functionally implicated in both
photic and non-photic modulation of the SCN [13,23,27,25,28,29].
The 5-HT actions are dependent on several serotonergic receptor
subtypes,which canbepre or post-synaptically positioned. To date,
the main subtypes of 5-HT receptors found in the SCN, character-
ized by biochemical and pharmacological approaches, belong to
the 5-HT1 family [26]. Also, in different species the subtype 5-HT1B
seems to prevail [12,30,33]. 5-HT1B receptors can be found in the
axon terminals of neurons (acting as a presynaptic modulator) or
in the postsynaptic cellular membrane [21].
The presence of 5-HT ﬁbers in the dorsal SCN of the marmoset
[31] motivated us to search the presence of serotonergic receptor
subtypes in the same species, so that, the aim of this study was to
identify and map the 5-HT1B receptor distribution comparing with
serotonergic and retinal innervations.
Four adult male marmosets (257–378g) from the Primatology
Center of the Federal University of Rio Grande do Norte (IBAMA
Open access under the Elsevier OA license.register 1/24/92/0039-0), Natal, Rio Grande do Norte, Brazil, were
used in this study. The animalswere housed under natural lighting,
temperature, and humidity conditions, with food and water freely
available. The maintenance and minimal use of the experimental
animals followed the guidelines of the Brazilian Society of Neuro-
oscien
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cience and Behavior under recommendations of the Guide for the
are andUseof LaboratoryAnimals inResearch (in accordancewith
he National Institutes of Health, NIH, USA).
Themarmosetswere deeply anesthetizedwith sodium thiopen-
al (Cristália, São Paulo, SP, Brazil, 40mg/kg, i.p.), placed on a
urgical table and received a topical application of tetracaine
ydrochloride in the cornea followed by a unilateral intraocular
njection of cholera toxin subunit B (CTb) (List Biological Lab-
ratories, Inc., Campbell, CA, USA). A total of 80l of 1mg/ml
queous CTb solution containing 10% dimethylsulfoxide was pres-
ure injected into the vitreous humor through a 30-gauge needle
atheter attached to a micropump, introducing the solution at a
ate of 1l/min. To minimize reﬂux and spread of the tracer to
he extraocular muscles and to avoid postoperative local infection,
he ocular surface was continuously cleansed with saline during
urgery. The ocular surface was then rewashed with saline and
n antibiotic ointment (Dexafenicol, Alergon, Brazil) was applied
opically. After 5–7 post-injection days, the marmosets were re-
nesthetized with sodium thiopental and transcardially perfused
ith 500ml of phosphate-buffered saline, pH7.4, containing 500 IU
f heparine (Parinex, Hipolabor, Brazil) followed by 700ml of 4%
araformaldehyde in 0.1M phosphate buffer (PB), pH 7.4. The
rains were removed from the skull, postﬁxed for 2–4h and trans-
erred to a solution containing 30% sucrose in PB.
Brain blocks from a point of a few millimeters anterior to
he optic chiasm through the midbrain were frozen and serially
ectioned in the coronal plane (30m) on a sliding microtome.
ections were sequentially collected and kept in PB in six sepa-
ate compartments. To establish the limits of the SCN, one of the
ix series of sections from each animal was stained with thionin
nd another was submitted to immunohistochemical reaction to
albindin (CB), a calcium-binding protein, which is reported to be a
sefulmarker for identifying the SCN boundaries in this species [6].
hree other series were used for the immunohistochemical detec-
ion of the CTb, 5-HT and 5-HT1B receptor. The remaining series
ere used to perform double labeling experiments combining 5-
T1B receptor and CB labels to analyze the arrangement of this
eceptor in relation to the SCN cells and nuclear architecture.
For the immunohistochemical detection of CTb, free ﬂoating
rain sections of the injected animal were incubated for 18h at
oom temperature (ca. 24 ◦C) using goat anti-CTb IgG (List Biolog-
cal Labs, Inc., Campbell, CA, USA), diluted at 1:5000, as primary
ntibody and 2% of normal donkey serum in 0.4% Triton X-100
n PB. The sections were then incubated with a biotinylated sec-
ndary antibody (donkey anti-goat IgG, Jackson Labs, Westgrove,
A, USA) diluted at 1:1000 for 90min. The sections were subse-
uently incubated with an avidin–biotin–peroxidase solution (ABC
lite kit, Vector Labs., Burlingame, CA, USA) for 90min. They were
hen reacted for peroxidase activity in a solution of diaminobenzi-
ine tetrahydrochloride (DAB, Sigma, St Louis, MO, USA) and 0.03%
2O2 in PB. The sections were washed with PB (5×5min) between
ach step and at the end of the procedure. For detection of the
B, 5-HT and 5-HT1B receptor, the same general procedure was
dopted using as primary antibodies a mouse anti-CB (Sigma, St
ouis, 1:5000), a rabbit anti-5HT (Immunostar, Hudson, WI, USA,
at # 20079, 1:5000), a guinea-pig anti-5HT1B (PharMinger, San
iego, CA, USA, cat # 550470, 1:500) and the respective secondary
ntibodies all raising in goat (Jackson Labs, Westgrove, PA, USA,
:1000). All of the incubations with primary antibody included 2%
ormal goat serum in 0.4% Triton X-100 in PB. Speciﬁcity tests and
he controls for the 5-HT label can be found at the company site
www.immunostar.com). The anti-5-HT1B was made in guinea pig
sing a synthetic peptide conjugated with bovine thyroglobulin
orresponding to aminoacids273–287withhomologue correspon-
ence in rodents, canines and primates. As for control procedures,
n some sections all the antibodies were used except the primaryce Letters 488 (2011) 6–10 7
antibody, which was substituted by normal serum or by incubation
of the secondary antibody only.
For the double labeling experiments, the tissue was simultane-
ously incubated with an antibody guinea pig anti-5-HT1B receptor
(PharMinger, San Diego, CA, USA) and a mouse-anti-CB (Sigma
Chemicals, St Louis, MO, USA), both at a dilution of 1:250 during
24h. The labeling was developed using secondary anti-guinea pig
ﬂuorescein-labeled and anti-mouse rhodamine-labeled antibodies
all made in donkey (Sigma, St Louis, MO, USA) at a 1:100 dilution
in PB with 0.4% Triton X-100. Proper immunoﬂuorescence con-
trols were performed by the omission of the primary and produced
lack of label. Material was examined under bright-ﬁeld illumina-
tion in an Olympus microscope for the single-label experiments
and in a Nikon E-800 epiﬂuorescence microscope for the double-
label experiments. The images were captured using a CCD camera
(Optronics Magnaﬁre, Goleta, CA, USA) and the composite images
were mounted with the aid of Adobe Photoshop (Adobe Software).
The distribution of labeled elements and staining intensity were
subjectively evaluated.
The SCN of the marmoset displays a triangular shape located
over the optic chiasm bilateral to the third ventricle as evidenced
in Nissl-stained coronal sections (Fig. 1A). The SCN CB-containing
neurons exhibit a clear label with visible and well delimited cell
bodies containing some apparent neuropil contrasting with adja-
cent hypothalamic areas (Fig. 1B). Retinal CTb-immunoreactive
ﬁbers in the common marmoset SCN were visualized in an unam-
biguous placement at its entire ventral portion with a noticeable
enlargement in the middle portion (Fig. 1C). This pattern appears
to be consistent from rostral to caudal levels showing a slight
decrease in intensity as the SCN extends toward the caudal direc-
tion. Fine 5-HT-immunoreactive ﬁbers/terminals were identiﬁed
in an apparently scattered distribution in the SCN of the mar-
moset (Fig. 1D). However, a more detailed observation shows that
these 5-HT positive ﬁbers exhibit a preferential distribution medi-
ally around the ventricle wall at the upper dorsal limit of the SCN
(Fig. 1D). In general, the disposition of the CTb-containing ﬁbers
overlap the 5-HT containing ﬁbers on the ventral portion of the
SCN, but the site of CTb exuberance coincides with the absence of
5-HT in an apparent complementary position in relation to RHT.
As for CTb, the 5-HT immunopattern appears to be constant from
rostral to caudal levels showing a slight decrease in intensity as the
SCN moves toward the caudal position.
5-HT1B immunoreactive (5-HT1B-IR) neurons show a broad and
apparent and homogeneous distribution in the hypothalamus of
the marmoset (Fig. 2A). In the entire rostro-caudal SCN the distri-
bution for the 5-HT1B-IRwasmore evident dorsally concentrated in
themedial contour near the ventriclewall, corresponding to higher
concentration of 5-HT innervation and letting an immunoreactive
free zone, which corresponds to the location of the bulk of RHT
ﬁbers (Fig. 2B and C). Most of the CB-positive neurons of the dorsal
district appear to be encircled by the dotted 5-HT1B label (Fig. 2D
and E).
The 5-HT1B immunoreactivity pattern in the SCN differs from
that of midbrain, which resembles postsynaptic neurons or autore-
ceptors since they appear to immunolabel the entire cell in the
dorsal raphe nucleus used now as a positive control label (Fig. 3A
and B). No label was observed in the control experiments (Fig. 3C
and D). For all parameters evaluated the results were similar in all
cases with only minor variations.
Evidences implicating 5-HT as a key neurotransmitter modu-
lating the effects of light on circadian rhythmicity is recurrent. For
example, the depletion of serotonergic input to the SCN of rodents
provokes a change of the circadian rhythms with an elongation
of the activity phase and disruption in constant light [22] and it
was proposed that this effect was mainly mediated by the 5-HT1B
receptor [30]. This subtype was observed to be associated with the
8 J.S. Cavalcante et al. / Neuroscience Letters 488 (2011) 6–10
Fig. 1. Digital images of coronal sections at hypothalamic level of the marmoset brain showing (A) the triangular shaped SCN at Nissl stained sections; (B) CB-immunostained
neurons ﬁlling all sectional area of the SCN; (C) distribution of CTb-retinal projections in the ventral portion (arrows) of the SCN; (D) 5-HT positive ﬁbers ramifying in the
medial and dorsal SCN, depriving the ventral area (arrows). The upper image in B (B′) is a detail of the CB-positive labeling in the SCN. Note the rounded nature of the small
neurons (average of 10m). 3v, third ventricle; oc, optic chiasm. Scale bar: 180m in A, 100m in B–D, 50m in B′ .
Fig. 2. Digital images of coronal sections of the marmoset brain at the SCN level showing (A) 5-HT1B-immunoexpression in all anterior hypothalamus, including the SCN;
(B) higher magniﬁcation of A showing 5-HT1B-positive structures with the dorsal portion containing the richest labeling (arrows); (C) higher magniﬁcation of the region
delimited by arrows in B showing the typical dot-like label pattern of 5-HT1B; (D) the merged exposure of CB-containing neurons visualized by TRITC-conjugated secondary
antiserum (red) and 5-HT1B-positive structures detected by FITC-conjugated secondary anti-serum (green); (E) higher magniﬁcation of the neurons indicated by arrows in
D. APL, preoptic lateral area; APM, preoptic medial area. Scale bar: 200m in A, 100m in B, 70m in C and D, 15m in E. (For interpretation of the references to color in
this ﬁgure legend, the reader is referred to the web version of the article.)
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tig. 3. Digital images of coronal sections of themarmoset brain showing 5-HT1B labe
B). Absence of labeling was evidenced in control experiments at DRN (C) and SCN (D
embrane of retinal terminals in the SCN suggesting that by this
resynaptic mechanism 5-HT can modify the response of the SCN
o light [30,29].More recently, 5-HT1B binding sitesweremassively
dentiﬁed in nonretinal terminals in the SCN, and combined phar-
acological and electrophysiological assays indicated that these
eceptors could be actually located on GABAergic terminals [3].
hus, the 5-HT1B inﬂuence on SCN neurons activity might be pro-
ided by inhibition of a GABA release in an intrinsic circuitry, most
ikely in the vicinity of afferent retinal ﬁbers.
Currently it is assumed that there be a correlation between 5-HT
nd RHT innervations with 5-HT1B in the ventral SCN, but in this
tudy we identiﬁed the occurrence of 5-HT1B receptors in the SCN
f the common marmoset more concentrated in the dorsal portion
oncurrentwith thepredominant locationof 5-HT immunoreactive
erminals. Our present experimental approach does not allow us to
etermine the precise elemental location of 5-HT1B receptors, but
ur data indicate that they could be acting as a presynaptic mod-
lator like in rodents. Thus, 5-HT1B immunoreactivity seemingly
round the cell body together with the lack of cytosolic label and
he absence of membrane contour strongly suggest its presynaptic
osition. Furthermore, the dot-like appearance and the topogra-
hy of the 5-HT1B immunoreactivity coincide with the presence of
-HT terminal ﬁbers. We observed that, although scarce, 5-HT1B-
mmunoreactivity was also detected in the marmoset ventral SCN,
nd we speculate that they are connected with putative GABAer-
ic ventral interneurons as reported in rodents [3]. However, it
ust be pointed out that the predominant labeling of the non-
etinorecipientdorsal SCNbea remarkabledifference inour results.
t this time we are unable to provide a deﬁnitive explanation for
his ﬁnding, however, it is possible that in the marmoset the 5-HT
odulates the SCN in an alternative way, in that we cannot dis-
ard a non-photic role. Pharmacological manipulation suggests the
articipation of the 5-HT1A and 7 subtypes in the phase advance
n behavioral circadian rhythms in hamster [8,24] that was inde-
endent of light inputs. This also reinforces the participation of
dditional subtypes conveying the 5-HT transmission [2].
In addition to the median raphe nucleus (MRN)–SCN pathway,
he dorsal raphe nucleus (DRN) projects to the IGL (DRN-IGL path-Nneurons (A) delimiting the neuronal body better evidenced at highmagniﬁcation
e, mesencephalic aqueduct. Scale bar: 200m in A and C, 30m in B, 100m in D.
way) and these twopathways appear to exhibit different functional
attributes in themammalCTS. 5-HTﬁbers fromtheMRNfacilitating
the synchronization of the animal to the light–dark cycle and the
disruption of the DRN-IGL do not inﬂuence this response [22]. The
reception of photic information by the raphe mesencephalic com-
plex through the retinal projections is well characterized and fully
recognized in some species [9–11] attributing to this system a piv-
otal role for 5-HT in circadian rhythmicity by indirect modulation
in response to light [23,27,28]. Furthermore, some data show that
the function of 5-HT in circadian rhythmicity goes beyond the light
response. This includes participation in sleep–wake cycle control
and food synchronization suggesting that the serotonergic system
takes part in the general organization of the photic-independent
mechanism [13,29]. Thewell-known rhythmic discharge rate of the
raphe neurons may have a tonic inﬂuence on the CTS, besides the
light inﬂuence. We also cannot visualize if the double shaped 5-HT
innervation in the marmoset SCN (present study) comes from dis-
tinct raphe nuclei. Whereas we cannot provide a prompt response
for that, it is already known that 5-HT receptors immunoreactivity
showacircadian rhythmin its expression indifferent ratbrainareas
[1], aswell as the 5-HT levels as a neurotransmitter, veriﬁed both in
the raphe complex [32] and in the innervation over the SCN [4]. The
SCNalsoexhibits an inherent capability to respond to the light–dark
cycle [36], which reinforces the power of intrinsic SCN circuitries
in order to maintain and adjust endogenous rhythmicity according
to environmental clues, not always exclusively light-dependent.
Lesions in the MRN and DRN or the use of serotonergic blockers
produce similar alterations in their targets, such as a loss of inhibi-
tion and increased discharge of SCN neurons [3,30]. In agreement
with this, 5-HT1B knockout mice display altered photic synchro-
nization and a reduced but not abolished light-induced phase shift
[33].
Until now, the occurrence of 5-HT1B has been more linked to
ventral SCN serotonergic innervation, and in our data we show
that in the marmoset this receptor appears to be preferentially dis-
tributed onCB-enriched neurons in themedio-dorsal portion of the
SCN.Even though the functional signiﬁcance remainsunknown,our
data imply that the 5-HT1B may inﬂuence the dorsal SCN seroton-
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rgic path, raising the possibility of a parallel feature in humans.
he 5-HT1B has been the focus of clinical studies on psychoso-
atic pathologies related to biological rhythms. An example is the
easonal affective disorder that affects patients living in short day
egions being consequently exposed to little sunlight [19]. Under-
tanding the functional attributes of 5-HT1B in the CTS seems to
e essential for investigation and possible future pharmacologic
anagement of these disorders.
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